When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Mitral regurgitation

Última revisão: 1 Dec 2025
Última atualização: 24 Jan 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • dyspnea on exertion
  • decreased exercise tolerance
  • lower extremity edema
  • holosystolic murmur
Detalhes completos

Outros fatores diagnósticos

  • fatigue
  • displaced point of maximal impulse
  • orthopnea
  • paroxysmal nocturnal dyspnea
  • palpitations
  • diaphoresis
  • pulmonary closure is louder than aortic closure
  • S3 heart sound
  • diminished S1 heart sound
Detalhes completos

Fatores de risco

  • mitral valve prolapse
  • history of rheumatic heart disease
  • infective endocarditis
  • history of cardiac trauma
  • history of myocardial infarction
  • history of congenital heart disease
  • history of ischemic heart disease
  • left ventricular systolic dysfunction
  • hypertrophic cardiomyopathy
  • anorectic/dopaminergic drugs
  • elevated systolic blood pressure
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • transthoracic echo
  • ECG
Detalhes completos

Investigações a serem consideradas

  • flow convergence method or proximal isovelocity surface area
  • color Doppler flow
  • transesophageal echocardiogram
  • cardiac catheterization
  • cardiac magnetic resonance imaging (CMR)
Detalhes completos

Algoritmo de tratamento

AGUDA

acute severe MR

CONTÍNUA

chronic severe primary MR: asymptomatic

chronic severe primary MR: symptomatic

chronic severe secondary MR

Colaboradores

Autores

Prakash P. Punjabi, FRCS, FESC, MS, MCh, FCCP, FFSTEd, Diplomate NBE

Professor

National Heart and Lung Institute

Imperial College London

Consultant Cardiothoracic Surgeon

Department of Cardiothoracic Surgery

Hammersmith Hospital

Imperial College Healthcare NHS Trust

London

UK

Declarações

PPP is an author of references cited in this topic. PPP declares that he has no competing interests.

Agradecimentos

Dr Prakash P. Punjabi would like to gratefully acknowledge Dr Samir Kapadia and Dr Mehdi H. Shishehbor, previous contributors to this topic.

Declarações

SK and MHS declare that they have no competing interests.

Revisores

Matthew Czarny, MD

Assistant Professor of Medicine

Department of Cardiovascular Medicine

Johns Hopkins University School of Medicine

Baltimore

MD

Declarações

MC is a paid consultant to Medtronic and receives research grants to the institution as a site principal investigator for clinical trials for Medtronic, MedAlliance, and Abbott and a sub-investigator for clinical trials for Edwards Lifesciences. All of these companies manufacture devices used in the transcatheter treatment of structural heart and/or coronary artery disease.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

De Bonis M, Al-Attar N, Antunes M, et al. Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. Eur Heart J. 2016 Jan 7;37(2):133-9.Texto completo  Resumo

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e72-227.Texto completo  Resumo

Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632.Texto completo  Resumo

Bonow RO, O'Gara PT, Adams DH, et al. 2020 focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 May 5;75(17):2236-70.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Mitral regurgitation images
  • Diagnósticos diferenciais

    • Acute coronary syndrome (ACS)
    • Infective endocarditis
    • Mitral stenosis
    Mais Diagnósticos diferenciais
  • Diretrizes

    • 2023 ESC guidelines for the management of infective endocarditis
    • 2021 ESC/EACTS guidelines for the management of valvular heart disease
    Mais Diretrizes
  • Videos

    Mitral regurgitation (severe)

    Third heart sound gallop

    Mais vídeos
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal